
Presented by
Management Forum
Get clear, actionable guidance on E6(R3) requirements for digital tools, AI, risk-based approaches, and quality-by-design. Learn how to apply them to trial conduct, oversight, and regulatory readiness using real-world examples.
13 July 2026 »
from £649
You may also be interested in...
This course focuses on the practical implications of the ICH GCP E6 (R3) guideline and what it means for the conduct and oversight of modern clinical trials. While the core principles of GCP remain unchanged, E6 (R3) introduces clearer expectations around risk-based approaches, oversight, roles and responsibilities, and the use of data and technology.
The course is designed to help clinical research professionals understand what has changed, how organisations are applying the new requirements in practice, and what regulators and inspectors are likely to focus on during GCP inspections.
Through practical examples, the session explores how sponsors, CROs and investigator sites are adapting governance, oversight, and decision-making under E6 (R3), with particular focus on inspection readiness.
By the end of the course, delegates will have a clear understanding of how to implement ICH GCP E6 (R3) in a practical and inspection-ready way.
Browse our extensive selection of Life Sciences training courses for industry-leading insights into a range of topics. These include Medical Devices, IVDs, Biotech and Biopharma, Animal Health and Pharmaceutical training courses.
This course is suitable for anyone involved in the planning, conduct, oversight, or support of clinical trials. It is applicable across Pharma, Biopharma, Clinical Research Organisations (CROs), service providers, and investigator sites.
While focused on ICH GCP E6(R3), the principles discussed are relevant to any organisation involved in the conduct and oversight of regulated clinical investigations.
The course is particularly relevant for:
Dr Laura Brown is an independent quality assurance and training consultant with extensive experience in clinical research and GCP compliance. She was formerly Course Director of the MSc in Clinical Research at the School of Pharmacy, Cardiff University, and Course Director of the MSc in Regulatory Affairs at the University of Hertfordshire.
Laura has managed and supported GCP inspections across the pharmaceutical industry and has held roles including Clinical Research Manager, Audit Director and Head of Training. She chaired the Institute of Clinical Research GCP Forum for six years and writes regularly on clinical research regulatory requirements, including ICH GCP E6 (R2) and (R3).
NEW higher discounts for multiple bookings - bring your colleagues to make your training budget go further:
Please contact us for pricing if you are interested in booking 5 or more delegates
13 July 2026
Live online
09:30-17:00 UK (London) (UTC+01)
10:30-18:00 Paris (UTC+02)
04:30-12:00 New York (UTC-04)
Course code 16055
Until 08 Jun
Not ready to book yet?
for 7 days, no obligation
* Early booking discounts may not be combined with other discounts or offers. As such, the discounts for 2nd/3rd/4th delegates are based on the full price; and apply only when booking multiple delegates on the same date.
Germany
United Kingdom
Pricing from:
We can customise this course to your requirements and deliver it on an in-house basis for any number of your staff or colleagues.
Contact our in-house training experts Aleksandra Beer and Yesim Nurko to discuss your requirements:
Multiple colleagues? See above for details of our discounts for 2, 3, or 4 delegates. For more, talk to one of our training experts to discuss how to: